Literature DB >> 1433093

Progress with a recombinant whooping cough vaccine: a review.

W N Burnette1, V L Mar, D W Whiteley, T D Bartley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1433093      PMCID： PMC1294608          DOI： 10.1177/014107689208500515

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  25 in total

Review 1.  The advent of recombinant pertussis vaccines.

Authors:  W N Burnette
Journal:  Biotechnology (N Y)       Date:  1990-11

2.  Mutants of pertussis toxin suitable for vaccine development.

Authors:  M Pizza; A Covacci; A Bartoloni; M Perugini; L Nencioni; M T De Magistris; L Villa; D Nucci; R Manetti; M Bugnoli
Journal:  Science       Date:  1989-10-27       Impact factor: 47.728

3.  Effects of mutations on enzyme activity and immunoreactivity of the S1 subunit of pertussis toxin.

Authors:  Y Lobet; W Cieplak; S G Smith; J M Keith
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

Review 4.  Neurotoxicity of Bordetella pertussis.

Authors:  M Pittman
Journal:  Neurotoxicology       Date:  1986       Impact factor: 4.294

5.  Acellular pertussis vaccines and fatal infections.

Authors:  M Kimura; H Kuno-Sakai
Journal:  Lancet       Date:  1988-04-16       Impact factor: 79.321

6.  Induction of a novel morphological response in Chinese hamster ovary cells by pertussis toxin.

Authors:  E L Hewlett; K T Sauer; G A Myers; J L Cowell; R L Guerrant
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

7.  Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections.

Authors:  H Sato; A Ito; J Chiba; Y Sato
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  Pertussis in Sweden after the cessation of general immunization in 1979.

Authors:  V Romanus; R Jonsell; S O Bergquist
Journal:  Pediatr Infect Dis J       Date:  1987-04       Impact factor: 2.129

9.  Identification of a region in the S1 subunit of pertussis toxin that is required for enzymatic activity and that contributes to the formation of a neutralizing antigenic determinant.

Authors:  W Cieplak; W N Burnette; V L Mar; K T Kaljot; C F Morris; K K Chen; H Sato; J M Keith
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

10.  A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells.

Authors:  M Tamura; K Nogimori; M Yajima; K Ase; M Ui
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.